Phytocannabinoids (news – undated) http://www.news-medical.net/health/P...nabinoids.aspx
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (full - 2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC31108/
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages (full – 2001) http://onlinelibrary.wiley.com/doi/1...1.00413.x/full
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. (full – 2002) http://www.iovs.org/content/43/10/3216.full
Endocannabinoid Degradation, Endotoxic Shock and Inflammation (link to PDF – 2002) http://www.eurekaselect.com/91915/article
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12384227
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron. (abst - 2002) http://www.ncbi.nlm.nih.gov/pubmed/12395075
Endocannabinoids and related fatty acid derivatives in pain modulation. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12505698
Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/11904167
Endocannabinoids in the central nervous system--an overview. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12052038
Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/14584958
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. (full – 2005) http://jpet.aspetjournals.org/content/314/2/868.long
Role of the endocannabinoid system in the development of tolerance to alcohol (full – 2005) http://alcalc.oxfordjournals.org/content/40/1/15.long
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15588725
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15763177
Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility. (full – 2006) http://www.iovs.org/content/47/5/1999.long
2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17292352
The role of the CB1 receptor in the regulation of sleep. (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
Unconventional neurotransmitters, neurodegeneration and neuroprotection (full – 2009) http://www.scielo.br/scielo.php?scri...lng=en&nrm=iso
Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. (full – 2010) http://www.jneurosci.org/content/30/18/6273.long
Endogenous cannabinoids in liver disease: Many darts for a single target (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19758727
Anti-proliferative Effect of a Putative Endocannabinoid, 2-Arachidonylglyceryl Ether in Prostate Carcinoma Cells (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. (abst – 2011) http://onlinelibrary.wiley.com/doi/1...f.131/abstract
Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402806/
The endocannabinoid system: an overview (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303140/
Stimulation of acumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22728691
Stimulatory and Inhibitory Roles of Brain 2-Arachidonoylglycerol in Bombesin-Induced Central Activation of Adrenomedullary Outflow in Rats. (full – 2013) https://www.jstage.jst.go.jp/article...1_12208FP/_pdf
2-Arachidonoylglycerol is a substrate for butyrylcholinesterase: a potential mechanism for extracellular endocannabinoid regulation. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23689009
Tricks and Tracks in the Identification and Quantification of Endocannabinoids (abst – 2013) http://onlinelibrary.wiley.com/doi/1...23407/abstract
The novel endocannabinoid noladin ether holds putative anti-fibrotic properties by selectively inducing cell death in hepatic stellate cells (abst – 2013) https://www.thieme-connect.com/ejour...s-0032-1331948
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (full - 2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC31108/
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages (full – 2001) http://onlinelibrary.wiley.com/doi/1...1.00413.x/full
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. (full – 2002) http://www.iovs.org/content/43/10/3216.full
Endocannabinoid Degradation, Endotoxic Shock and Inflammation (link to PDF – 2002) http://www.eurekaselect.com/91915/article
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12384227
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron. (abst - 2002) http://www.ncbi.nlm.nih.gov/pubmed/12395075
Endocannabinoids and related fatty acid derivatives in pain modulation. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12505698
Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/11904167
Endocannabinoids in the central nervous system--an overview. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12052038
Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether. (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/14584958
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. (full – 2005) http://jpet.aspetjournals.org/content/314/2/868.long
Role of the endocannabinoid system in the development of tolerance to alcohol (full – 2005) http://alcalc.oxfordjournals.org/content/40/1/15.long
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15588725
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15763177
Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility. (full – 2006) http://www.iovs.org/content/47/5/1999.long
2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17292352
The role of the CB1 receptor in the regulation of sleep. (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
Unconventional neurotransmitters, neurodegeneration and neuroprotection (full – 2009) http://www.scielo.br/scielo.php?scri...lng=en&nrm=iso
Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. (full – 2010) http://www.jneurosci.org/content/30/18/6273.long
Endogenous cannabinoids in liver disease: Many darts for a single target (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19758727
Anti-proliferative Effect of a Putative Endocannabinoid, 2-Arachidonylglyceryl Ether in Prostate Carcinoma Cells (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. (abst – 2011) http://onlinelibrary.wiley.com/doi/1...f.131/abstract
Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402806/
The endocannabinoid system: an overview (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303140/
Stimulation of acumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22728691
Stimulatory and Inhibitory Roles of Brain 2-Arachidonoylglycerol in Bombesin-Induced Central Activation of Adrenomedullary Outflow in Rats. (full – 2013) https://www.jstage.jst.go.jp/article...1_12208FP/_pdf
2-Arachidonoylglycerol is a substrate for butyrylcholinesterase: a potential mechanism for extracellular endocannabinoid regulation. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23689009
Tricks and Tracks in the Identification and Quantification of Endocannabinoids (abst – 2013) http://onlinelibrary.wiley.com/doi/1...23407/abstract
The novel endocannabinoid noladin ether holds putative anti-fibrotic properties by selectively inducing cell death in hepatic stellate cells (abst – 2013) https://www.thieme-connect.com/ejour...s-0032-1331948